In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies

1. Cabezas, D.
2. Mellado, G.
3. Espinoza, N.
4. Gárate, J.A.
5. Morales, C.
6. Castro-Alvarez, A.
7. Matos, M.J.
8. Mellado, M.
9. Mella, J.